SavedAdd your journal

Journals / Türk Klinik Biyokimya Dergisi / 2018 / Cilt: 16 - Sayı: 1

Median Values of Double and Triple Prenatal Screening Tests: A Van Scale Restrospective Study

İkili ve Üçlü Prenatal Tarama Testi Medyan Değerleri: Van Ölçekli Retrospektif Bir Çalışma

Hamit Hakan ALP
Mehmet Ramazan ŞEKEROĞLU
Erdem ÇOKLUK
Zübeyir HUYUT
Pages
17–24
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The new median values of β-hCG were significantly lower than the median values of the program (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to determine the new median values of biochemical analytes used in double and triple prenatal screening tests and to compare these values with the median values of the package program used in screening tests.
📊
Key Findings & Data:Materials and Methods: This study was carried out by obtaining retrospective results of beta-human chorionic gonadotrophin (β-hCG) and pregnant associated plasma protein-A (PAPP-A), alpha-fetoprotein (AFP) and unconjugated estriol (uE3) in which the double and triple prenatal screening tests were performed between October 2013 and October 2015 in the Biochemistry laboratory of Dursun Odabaşı Medical Center of Van Yüzüncü Yıl University.
💡
Conclusion & Impact:The new median values of β-hCG were significantly lower than the median values of the program (p
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to determine the new median values of biochemical analytes used in double and triple prenatal screening tests and to compare these values with the median values of the package program used in screening tests. Materials and Methods: This study was carried out by obtaining retrospective results of beta-human chorionic gonadotrophin (β-hCG) and pregnant associated plasma protein-A (PAPP-A), alpha-fetoprotein (AFP) and unconjugated estriol (uE3) in which the double and triple prenatal screening tests were performed between October 2013 and October 2015 in the Biochemistry laboratory of Dursun Odabaşı Medical Center of Van Yüzüncü Yıl University. Results: New median values were calculated from the data between 11-14 weeks free β-hCG and the PAPP-A in the double screening test and compared with the data in Prisca package program. The new median values of β-hCG were significantly lower than the median values of the program (p

Özet

Amaç: Bu çalışmadaki amacımız, ikili ve üçlü prenatal tarama testlerinde kullanılan biyokimyasalanalitlerin, bölgemize ait yeni medyan değerlerini belirlemek ve bu değerleri tarama testlerindekullanılan paket programdaki medyan değerleri ile karşılaştırmaktır.Gereç ve Yöntem: Bu çalışma, Van Yüzüncü Yıl Üniversitesi Dursun Odabaşı Tıp Merkezi Biyokimyalaboratuvarında Ekim 2013 – Ekim 2015 tarihleri arasında ikili ve üçlü prenatal tarama testleri yapılangebelerin geriye dönük beta-human koryonik gonadotropin (β-hCG), gebelik ilişkili plazma protein-A(PAPP-A), alfa fetoprotein (AFP) ve ankonjuge östriol-3 (uE3) sonuçları temin edilerek yürütüldü.Bulgular: İkili tarama testinde yer alan β-hCG ve PAPP-A’nın 11-14. haftalar arasındaki verilerinden yenimedyan değerleri hesaplandı ve Prisca paket programında yer alan medyan değerleri ile karşılaştırıldı.β-hCG’nin yeni medyan değerlerinin, programdaki medyan değerlerinden anlamlı olarak düşük olduğutespit edilirken (p0.05). Aynı işlemler üçlütarama testinde yer alan analitler için de yapıldı ve AFP, β-hCG ve uE3 için yeni hesaplanan medyanverilerinin, programda yer alan medyan verilerinden anlamlı olarak farklı olduğu görüldü (p

🔖

Cite This Article

ALP, H. H., ŞEKEROĞLU, M. R., ÇOKLUK, E., HUYUT, Z. (2022). Median Values of Double and Triple Prenatal Screening Tests: A Van Scale Restrospective Study. Türk Klinik Biyokimya Dergisi, Cilt: 16 - Sayı: 1, 17–24. https://ajindex.com/articles/634385

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alphafetoprotein in relation to neural-tube defects. Lancet. 1977;1(8026):1323-32.
  2. James DK, Steer, P.J., Weiner, C.P., Yüksek Riskli Gebelikler Yönetim Seçenekleri. In: Güner H, editor. Erkan Prenatal Bakım. İstanbul: Güneş Tıp Kitapevleri; 2008. p. 65. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Bmj. 1992;304(6831):867-9.
  3. Brizot ML, Snijders RJ, Bersinger NA, Kuhn P, Nicolaides KH. Maternal serum pregnancyassociated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol. 1994;84(6):918-22.
  4. Noble PL, Abraha HD, Snijders RJ, Sherwood R, Nicolaides KH. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness. Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 1995;6(6):390-5. Cuckle H. Integrating antenatal Down's syndrome screening. Curr Opin Obstet Gynecol. 2001;13(2): 175-81.
  5. Kagan KO, Sonek J, Wagner P, Hoopmann M. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities. Archives of gynecology and obstetrics. 2017;296(4):645-51.
  6. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Journal of medical screening. 2003;10(2):56-104.
  7. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. New Engl J Med. 2005;353(19):2001-11.
  8. Carmichael JB, Liu HP, Janik D, Hallahan TW, Nicolaides KH, Krantz DA. Expanded conventional first trimester screening. Prenat Diagn. 2017; 37(8):802-7.
  9. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of falsepositive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn. 1992;12(3):205-14.
  10. Ananth CV, Wapner RJ, Ananth S, D'Alton ME, Vintzileos AM. First-Trimester and Second-Trimester Ma